{
    "2021-09-17": [
        [
            {
                "time": "",
                "original_text": "探索财富密码｜玻尿酸X号玩家高调入局食品业，华熙生物的成长天花板在哪？",
                "features": {
                    "keywords": [
                        "玻尿酸",
                        "食品业",
                        "华熙生物",
                        "成长天花板"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗器械行业：胶原新生 遇见未来",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "胶原新生"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华熙生物今日大宗交易成交114万股，成交价150.99元折价11.7%",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "大宗交易",
                        "折价"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-09-17",
                "original_text": "A股资金流向（9月17日）：消费、资源跷跷板效应显著",
                "features": {
                    "keywords": [
                        "A股",
                        "资金流向",
                        "消费",
                        "资源",
                        "跷跷板效应"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "资源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华熙生物(688363)：品牌矩阵贯穿医护两端 三地产能实现四轮驱动",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "品牌矩阵",
                        "医护两端",
                        "产能",
                        "四轮驱动"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "珀莱雅(603605)深度报告：主品牌升级 新渠道助力 多品牌可期",
                "features": {
                    "keywords": [
                        "珀莱雅",
                        "主品牌升级",
                        "新渠道",
                        "多品牌"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化妆品",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}